Tag: Hemas Sustains Q1 Revenue Amid Market Volatility; Sharpens Focus on Margin Recovery

Hemas delivered revenue growth of 0.9% YoY to Rs. 28.77 Bn in Q1 FY27, supported by growth in Consumer Brands, Hospitals and Mobility. Gross profit margin improved to 30.4%, demonstrating the benefits of pricing actions and portfolio mix improvements.  The escalation of conflict in the Middle East led to rising global fuel, freight and raw […]